文献速递肺结节与肺癌

胸膜活检实现分子分型:多中心回顾性队列研究

Achieving Molecular Profiling in Pleural Biopsies: A Multicenter, Retrospective Cohort Study.
PubMed 文献 · Chest · 2022-11-19

该多中心回顾性队列研究分析183例恶性胸腔积液患者,比较不同胸膜活检技术获取分子标志物信息的充分性。

要点

  • LAT获取分子标志物成功率95%,显著优于CT引导86%和超声引导77%。
  • 活检技术和标本大小是成功分子分析的独立预测因素。
  • LAT成功诊断的校正OR为30.16,标本每增加1mm OR为1.18。

核心结论

  • 在靶向治疗时代,LAT在获取分子分型方面远优于影像引导技术,仍是最佳诊断工具。

研究设计与样本

  • 多中心回顾性队列研究,纳入3个国家4个中心的183例经胸膜活检确诊恶性肿瘤且分子分型与癌症类型相关的患者。

主要发现

  • 183例中,LAT 105例(57%),CT引导12例(7%),超声引导66例(36%)。

临床怎么用

  • 在需要分子分型指导治疗的恶性胸腔积液患者中,优先考虑LAT以获取充足组织。

局限性

  • 回顾性研究设计,样本来自4个中心,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pleural biopsy findings offer greater diagnostic sensitivity in malignant pleural effusions compared with pleural fluid. The adequacy of pleural biopsy techniques in achieving molecular marker status has not been studied, and such information (termed "actionable" histology) is critical in providing a rational, efficient, and evidence-based approach to diagnostic investigation. RESEARCH QUESTION: What is the adequacy of various pleural biopsy techniques at providing adequate molecular diagnostic information to guide treatment in malignant pleural effusions? STUDY DESIGN AND METHODS: This study analyzed anonymized data on 183 patients from four sites across three countries in whom pleural biopsy results had confirmed a malignant diagnosis and molecular profiling was relevant for the diagnosed cancer type. The primary outcome measure was adequacy of pleural biopsy for achieving molecular marker status. Secondary outcomes included clinical factors predictive of achieving a molecular diagnosis. RESULTS: The median age of patients was 71 years (interquartile range, 63-78 years), with 92 of 183 (50%) male. Of the 183 procedures, 105 (57%) were local anesthetic thoracoscopies (LAT), 12 (7%) were CT scan guided, and 66 (36%) were ultrasound guided. Successful molecular marker analysis was associated with mode of biopsy, with LAT having the highest yield and ultrasound-guided biopsy the lowest (LAT vs CT scan guided vs ultrasound guided: LAT yield, 95%; CT scan guided, 86%; and ultrasound guided, 77% [P = .004]). Biopsy technique and size of biopsy sample were independently associated with successful molecular marker analysis. LAT had an adjusted OR for successful diagnosis of 30.16 (95% CI, 3.15-288.56; P = .003) and biopsy sample size an OR of 1.18 (95% CI, 1.02-1.37) per millimeter increase in tissue sample size (P < .03). INTERPRETATION: Although previous studies have shown comparable overall diagnostic yields, in the modern era of targeted therapies, this study found that LAT offers far superior results to image-guided techniques at achieving molecular profiling and remains the optimal diagnostic tool.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Sundaralingam A, Aujayeb A, Akca B, et al. Achieving Molecular Profiling in Pleural Biopsies: A Multicenter, Retrospective Cohort Study. Chest. 2022. PMID: 36410492. doi:10.1016/j.chest.2022.11.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。